1. Home
  2. FLGT vs SIBN Comparison

FLGT vs SIBN Comparison

Compare FLGT & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • SIBN
  • Stock Information
  • Founded
  • FLGT 2011
  • SIBN 2008
  • Country
  • FLGT United States
  • SIBN United States
  • Employees
  • FLGT N/A
  • SIBN N/A
  • Industry
  • FLGT Medical Specialities
  • SIBN Medical/Dental Instruments
  • Sector
  • FLGT Health Care
  • SIBN Health Care
  • Exchange
  • FLGT Nasdaq
  • SIBN Nasdaq
  • Market Cap
  • FLGT 683.5M
  • SIBN 547.3M
  • IPO Year
  • FLGT 2016
  • SIBN 2018
  • Fundamental
  • Price
  • FLGT $16.37
  • SIBN $17.85
  • Analyst Decision
  • FLGT Hold
  • SIBN Strong Buy
  • Analyst Count
  • FLGT 1
  • SIBN 6
  • Target Price
  • FLGT $22.00
  • SIBN $23.00
  • AVG Volume (30 Days)
  • FLGT 226.5K
  • SIBN 312.2K
  • Earning Date
  • FLGT 02-26-2025
  • SIBN 02-24-2025
  • Dividend Yield
  • FLGT N/A
  • SIBN N/A
  • EPS Growth
  • FLGT N/A
  • SIBN N/A
  • EPS
  • FLGT N/A
  • SIBN N/A
  • Revenue
  • FLGT $277,761,000.00
  • SIBN $157,035,000.00
  • Revenue This Year
  • FLGT N/A
  • SIBN $21.56
  • Revenue Next Year
  • FLGT $16.00
  • SIBN $17.15
  • P/E Ratio
  • FLGT N/A
  • SIBN N/A
  • Revenue Growth
  • FLGT N/A
  • SIBN 18.98
  • 52 Week Low
  • FLGT $16.07
  • SIBN $11.70
  • 52 Week High
  • FLGT $26.37
  • SIBN $21.64
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 34.14
  • SIBN 62.22
  • Support Level
  • FLGT $16.68
  • SIBN $15.95
  • Resistance Level
  • FLGT $17.27
  • SIBN $17.65
  • Average True Range (ATR)
  • FLGT 0.70
  • SIBN 0.79
  • MACD
  • FLGT -0.05
  • SIBN 0.01
  • Stochastic Oscillator
  • FLGT 13.20
  • SIBN 77.39

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Share on Social Networks: